Myriad Genetics

SAGE Therapeutics

Intra-Cellular Therapies

GH Research PLC

ACADIA Pharma

PTC Therapeutics

Karuna Therapeutics Inc

Sarepta Therapeutics

Alkermes

Biogen

PSYK ETF

PSYK tracks an index of companies with business activities in  psychedelic treatments and neurology biopharmaceuticals. Stocks are selected using a natural process algorithm and weighted by market-cap within the fund.

OKLAHOMA CITY , Feb. 27, 2023 /PRNewswire/ -- After careful consideration, Exchange Traded Concepts, LLC, the investment adviser to the PSYK ETF (the "Fund"), in consultation with Elemental Advisors Inc., the Fund's sponsor, has recommended, and the Board of Trustees of ETF Series Solutions has approved, the termination and liquidation of the Fund pursuant to the terms of a Plan of Liquidation. Accordingly, the Fund is expected to cease operations and liquidate on or about March 28, 2023 (the "Liquidation Date").

Exchange Traded Concepts to Close and Liquidate the PSYK ETF

Atai Life Sciences BV

COMPASS Pathways

Cybin

Mind Medicine MindMed

Defiance Next Gen Altered Experience ETF

Seelos Therapeutics

Advisorshares Psychedelics ETF

On July 13, 2022, two amendments passed in the House of Representatives that would provide psychedelic drug treatment to veterans and active duty service members. A documentary based on Michael Pollan's 2018 book, "How to Change Your Mind," is one of Netflix's most-watched shows.

The Growth Potential Of Psychedelics Stocks And ETFs

A new thematic ETF providing exposure to the medicinal psychedelic drug industry, PSYK ETF, has just been launched.

Diversify Your Portfolio With a New Psychedelic Drug ETF

Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF PSYK tracks the Enhanced Consciousness Index.

New Psychedelics ETF Launches On NYSE Arca

First-time issuer Elemental Advisors is the latest to create an ETF for the burgeoning industry.

3rd Psychedelics ETF Launches

Elemental Advisors just launched the PSYK ETF (NYSE Arca: PSYK), a thematic ETF focused on the emerging use of psychedelic compounds in treating mental health issues. Tim Collins, a founder and president of Elemental Advisors, recently provided some insight as to why the company decided to make this its first issued ETF, how the medicinal [.

Elemental Advisors President Talks Investing in Psychedelics Through PSYK

SARASOTA, Fla.--(BUSINESS WIRE)--Elemental Advisors Inc. (“Elemental Advisors”) is pleased to announce the launch of PSYK ETF (NYSE: PSYK), a thematic ETF that tracks the performance of the Enhanced Consciousness Index (the “Index”), which is principally comprised of companies involved in the research, development, production and/or use of psychedelics to address medical conditions in legal pharmacological applications under the applicable jurisdiction's laws. As one of the first U.S. listed ps

News for PSYK ETF ETF (PSYK)